Q&A: Navigating tech transfer and production pitfalls

Successful tech transfer alignment requires robust risk management and precise operational planning. When communication gaps or unforeseen supply chain hurdles emerge, project timelines and product quality are often the first to be affected. In this Q&A, we explore the common pitfalls of pharmaceutical tech transfers, including how to protect critical milestones without compromising safety and the essential tools to help navigate production uncertainties.

Why do alignment issues occur during tech transfer, and how can pharma companies mitigate this risk?

From a pharmaceutical perspective, tech transfer risks arise when there is a disconnect between the negotiated contracts and the technical teams executing them. Misaligned timelines and sudden scope creep can frequently delay project kickoffs. This risk can be mitigated by partnering with a contract development and manufacturing organization (CDMO) that operates as a seamless extension of the pharma team, driven by transparent information sharing and precise scope definition from day one.

We can leverage a variety of alignment strategies to address scope ambiguity in tech transfer, including a structured scope document that categorizes deliverables into three distinct tiers. This framework explicitly separates the baseline contracted work scope from immediate project needs that require a change order, as well as future “nice-to-have” options to be quoted later. This type of clear documentation is just one way to prevent misalignment, allowing teams to execute efficiently and confidently hit critical regulatory submission dates.

When tech transfer timelines get compressed, what are the non-negotiables for maintaining project integrity?

Patient safety and product quality are completely non-negotiable. When timelines compress, successful execution relies on managing risk rather than cutting corners. For example, although it isn’t strictly prohibited by regulations, bypassing a best-practice engineering batch to rush straight to a good manufacturing practice (GMP) batch introduces risks. These engineering runs are vital to resolve equipment, material and personnel issues before GMP manufacturing begins.

When working to compressed timelines, it’s also important to have open and honest communication. At Kindeva, we can use interactive, real-time dashboards to track project requirements and prevent scope creep. We operate on the principle that a methodical approach is the fastest path forward. This means taking the necessary time to deliver the first time correctly, eliminating the potentially devastating delays caused by deviations and batch rejections.

What are the most surprising production and supply chain challenges, and how can teams manage that uncertainty?

Teams are frequently tripped up by minor, overlooked technical details such as last-minute changes to a filter, tubing size or filling needle. These small oversights can stall an entire production run. To manage this uncertainty, teams require a bill of materials with as much detail as possible and disciplined material trackers.

An effective material tracker monitors a component’s lifecycle from specification and ordering through to testing and final release. While these processes seem routine at a macro level, managing their intricate, micro-level moving parts is where project execution is truly won or lost, which underscores why a dedicated tracker is essential for maintaining total visibility and momentum.

On the production side, avoiding unexpected constraints requires sophisticated capacity planning tools that accurately map out equipment and fill lines. While spreadsheets can work, advanced planning software combined with accurate, long-term forecasting allows us to secure necessary capacity and specialized equipment often 18-to-24 months in advance, ensuring long-term supply chain resilience.

Contact us today to discuss how our experts can support your next tech transfer project.